These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 31698775)

  • 1. Pivotal Role of STAT3 in Shaping Glioblastoma Immune Microenvironment.
    Piperi C; Papavassiliou KA; Papavassiliou AG
    Cells; 2019 Nov; 8(11):. PubMed ID: 31698775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights in the immunobiology of glioblastoma.
    Strepkos D; Markouli M; Klonou A; Piperi C; Papavassiliou AG
    J Mol Med (Berl); 2020 Jan; 98(1):1-10. PubMed ID: 31650201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of STAT3 in glioblastoma progression through dual influences on tumor cells and the immune microenvironment.
    Chang N; Ahn SH; Kong DS; Lee HW; Nam DH
    Mol Cell Endocrinol; 2017 Aug; 451():53-65. PubMed ID: 28089821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-Cell RNA-Sequencing Shift in the Interaction Pattern Between Glioma Stem Cells and Immune Cells During Tumorigenesis.
    Zhai Y; Li G; Li R; Chang Y; Feng Y; Wang D; Wu F; Zhang W
    Front Immunol; 2020; 11():581209. PubMed ID: 33133100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SH3BGRL3, transcribed by STAT3, facilitates glioblastoma tumorigenesis by activating STAT3 signaling.
    Nie Z; Cheng D; Pan C; Wei Z; Wang C; Wang C
    Biochem Biophys Res Commun; 2021 Jun; 556():114-120. PubMed ID: 33839406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy.
    Shibahara I; Saito R; Zhang R; Chonan M; Shoji T; Kanamori M; Sonoda Y; Kumabe T; Kanehira M; Kikuchi T; So T; Watanabe T; Takahashi H; Iwabuchi E; Tanaka Y; Shibahara Y; Sasano H; Ishii N; Tominaga T
    Mol Cancer; 2015 Feb; 14():41. PubMed ID: 25744203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of STAT3 in Genesis and Progression of Human Malignant Gliomas.
    Ouédraogo ZG; Biau J; Kemeny JL; Morel L; Verrelle P; Chautard E
    Mol Neurobiol; 2017 Oct; 54(8):5780-5797. PubMed ID: 27660268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Dynamics of Interactions Among Immune and Glioblastoma Cells.
    Eder K; Kalman B
    Neuromolecular Med; 2015 Dec; 17(4):335-52. PubMed ID: 26224516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of STAT3 and hypoxia markers in long-term surviving malignant glioma patients.
    Dvorakova K; Skarkova V; Vitovcova B; Soukup J; Vosmikova H; Pleskacova Z; Skarka A; Bartos MC; Krupa P; Kasparova P; Petera J; Rudolf E
    BMC Cancer; 2024 Apr; 24(1):509. PubMed ID: 38654280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation of tumor-immune symbiosis in glioma.
    Liu Y; Ali H; Khan F; Pang L; Chen P
    Trends Mol Med; 2024 May; 30(5):429-442. PubMed ID: 38453529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators.
    Lo HW; Cao X; Zhu H; Ali-Osman F
    Clin Cancer Res; 2008 Oct; 14(19):6042-54. PubMed ID: 18829483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of SH3GL2 promotes the migration and invasion behaviours of glioblastoma cells through activating the STAT3/MMP2 signalling.
    Zhu Y; Zhang X; Wang L; Ji Z; Xie M; Zhou X; Liu Z; Shi H; Yu R
    J Cell Mol Med; 2017 Nov; 21(11):2685-2694. PubMed ID: 28470949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interplay between glioblastoma and microglia cells leads to endothelial cell monolayer dysfunction via the interleukin-6-induced JAK2/STAT3 pathway.
    Couto M; Coelho-Santos V; Santos L; Fontes-Ribeiro C; Silva AP; Gomes CMF
    J Cell Physiol; 2019 Nov; 234(11):19750-19760. PubMed ID: 30937892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive Myeloid Cells' Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy.
    Kamran N; Kadiyala P; Saxena M; Candolfi M; Li Y; Moreno-Ayala MA; Raja N; Shah D; Lowenstein PR; Castro MG
    Mol Ther; 2017 Jan; 25(1):232-248. PubMed ID: 28129117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation.
    Leidgens V; Proske J; Rauer L; Moeckel S; Renner K; Bogdahn U; Riemenschneider MJ; Proescholdt M; Vollmann-Zwerenz A; Hau P; Seliger C
    Oncotarget; 2017 Jan; 8(5):8250-8263. PubMed ID: 28030813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma.
    DeCordova S; Shastri A; Tsolaki AG; Yasmin H; Klein L; Singh SK; Kishore U
    Front Immunol; 2020; 11():1402. PubMed ID: 32765498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Cytolytic Activity Is Associated With Genetic and Clinical Properties of Glioma.
    Wang ZL; Wang Z; Li GZ; Wang QW; Bao ZS; Zhang CB; Jiang T
    Front Immunol; 2019; 10():1756. PubMed ID: 31428092
    [No Abstract]   [Full Text] [Related]  

  • 18. Signal transducer and activator of transcription 1 (Stat1) maintains basal mRNA expression of pro-survival stat3-target genes in glioma C6 cells.
    Adach-Kilon A; Swiatek-Machado K; Kaminska B; Dabrowski M
    J Cell Biochem; 2011 Dec; 112(12):3685-94. PubMed ID: 21815198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NFAT1-Mediated Regulation of NDEL1 Promotes Growth and Invasion of Glioma Stem-like Cells.
    Jiang Y; Song Y; Wang R; Hu T; Zhang D; Wang Z; Tie X; Wang M; Han S
    Cancer Res; 2019 May; 79(10):2593-2603. PubMed ID: 30940662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paired related homeobox 1 transactivates dopamine D2 receptor to maintain propagation and tumorigenicity of glioma-initiating cells.
    Li Y; Wang W; Wang F; Wu Q; Li W; Zhong X; Tian K; Zeng T; Gao L; Liu Y; Li S; Jiang X; Du G; Zhou Y
    J Mol Cell Biol; 2017 Aug; 9(4):302-314. PubMed ID: 28486630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.